These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23740091)

  • 1. Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas.
    You Y; Yang W; Wang Z; Zhu H; Li H; Lin C; Ran Y
    Cell Oncol (Dordr); 2013 Jul; 36(4):323-31. PubMed ID: 23740091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
    Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
    BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
    Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
    Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
    Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
    Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
    Li J; Gong P; Lyu X; Yao K; Li X; Peng H
    Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
    Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q
    Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.
    Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G
    J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.
    You Y; Yang W; Qin X; Wang F; Li H; Lin C; Li W; Gu C; Zhang Y; Ran Y
    Cell Oncol (Dordr); 2015 Jun; 38(3):205-14. PubMed ID: 25707757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
    Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z
    BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.
    Yi HM; Li H; Peng D; Zhang HJ; Wang L; Zhao M; Yao KT; Ren CP
    Oncol Res; 2006; 16(6):261-72. PubMed ID: 17476971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy.
    Ran Y; Wu S; You Y
    J Biochem; 2011 Jan; 149(1):49-54. PubMed ID: 21059597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic downregulation of the ISG15-conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma.
    Zhou X; Wei J; Chen F; Xiao X; Huang T; He Q; Wang S; Du C; Mo Y; Lin L; Xie Y; Wei L; Lan Y; Murata M; Huang G; Ernberg I; Matskova L; Zhang Z
    Oncotarget; 2015 Dec; 6(38):41077-91. PubMed ID: 26506425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma.
    He D; Zeng Q; Ren G; Xiang T; Qian Y; Hu Q; Zhu J; Hong S; Hu G
    Eur J Cancer Prev; 2012 Nov; 21(6):569-75. PubMed ID: 22273848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD81 is a candidate tumor suppressor gene in human gastric cancer.
    Yoo TH; Ryu BK; Lee MG; Chi SG
    Cell Oncol (Dordr); 2013 Apr; 36(2):141-53. PubMed ID: 23264205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
    Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G
    Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hypermethylated RIZ1 gene in primary tumor, mouth, and throat rinsing fluid, nasopharyngeal swab, and peripheral blood of nasopharyngeal carcinoma patient.
    Chang HW; Chan A; Kwong DL; Wei WI; Sham JS; Yuen AP
    Clin Cancer Res; 2003 Mar; 9(3):1033-8. PubMed ID: 12631603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.